Filoviral haemorrhagic fevers

British Medical Bulletin

Volumn 54, Issue 3, 1998, Pages 675-692

  Khan, Ali S ^a   Sanchez, Anthony ^a   Pflieger, Anne K ^a,b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

BLOOD ANALYSIS; CLINICAL FEATURE; CONVALESCENCE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FILOVIRIDAE; GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; HEMORRHAGIC FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; LABORATORY TEST; MARBURG VIRUS; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MONKEY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIMATE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEROLOGY; VIRUS INFECTION; VIRUS ISOLATION;

EID: 0031782167     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011719     Document Type: Review

References (86)

1. Coleman M, Scurlock J. Viral hemorrhagic fevers in ancient Mesopotamia. Trop Med Int Health 1997; 2: 603-6
2. Jarhling PB, Kiley MP, Klenk HD et al. Family Filoviridae. Arch Virol 1995; 10 (Suppl): 289-92
3. Kissling R, Robinson RQ, Murphy FA et al. Agent of disease contracted from green monkeys. Science 1968; 160: 888-90
4. Murphy FA, Van der Groen G, Whitfield SG, Lange JV. Ebola and Marburg virus morphology and taxonomy. In: Pattyn SR. (ed) Ebola virus haemorrhagic fever. Amsterdam: Elsevier/North-Holland, 1978.
5. Geisbert TW, Jahrling PB, Hanes MA et al. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J Comp Pathol 1992; 106: 137-52
6. Regnery RL, Johnson KM, Kiley MP. Virion nucleic acid of Ebola virus. J Virol 1980; 36: 465-9
7. Bukreyev AA, Volchkov VE, Blinov VM et al. The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: a comparison with the Musoke (1980) strain. Arch Virol 1995; 140: 1589-600
8. Feldmann H, Mühlberger E, Randolf A et al. Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res 1992; 24: 1-19
9. Sanchez A, Kiley MP, Holloway BP et al. The nucleoprotein gene of Ebola virus: cloning, sequencing and in vitro expression. Virology 1989; 170: 81-91
10. Sanchez, A, Kiley MP, Holloway BP et al. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res 1993; 29: 215-40
11. Suzuki Y, Gojobori T. The origin and evolution of Ebola and Marburg viruses. Mol Biol Evol 1997; 14: 800-6
12. Sanchez A, Trappier SG, Mahy BWJ et al. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci USA 1996; 93: 3602-7
13. Georges-Courbot MC, Lu CY, Lansoud-Soukate J et al. Isolation and partial molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon. Lancet 1997; 349: 181
14. Rodriguez L, De Roo A, Guimard Y et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Zaire, 1995. J Infect Dis 1998; In press
15. Sanchez A, Trappier SG, Ströher U et al. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology 1998; 240: 138-46
16. Sanchez A, Ksiazek TG, Rollin PE et al. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis 1998; In press
17. Martini GA, Siegert R. (eds) Marburg Virus Disease. Berlin: Springer, 1971
18. Slenczka W, Wolff G, Siegert R. A critical study of monkey sera for the presence of antibody against the Marburg virus. Am J Epidemiol 1971; 93: 496-505
19. Gear JSS, Cassel GA, Gear AJ et al. Outbreak of Marburg virus disease in Johannesburg. BMJ 1975; 4: 489-93
20. Smith DH, Johnson BK, Isacson M et al. Marburg virus disease in Kenya. Lancet 1982; 1: 816-20
21. Johnson ED, Johnson BK, Silverscein D et al. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol 1996; 11 (Suppl): 101-14
22. World Health Organization. Ebola haemorrhagic fever in Zaire, 1976, Report of an international commission. Bull World Health Organ 1978; 56: 271-93
23. World Health Organization. Ebola haemorrhagic fever in Sudan, 1976. Report of a World Health Organization International Study Team. Bull World Health Organ 1978; 56: 247-70
24. Emond RTD, Evans B, Bowen ETW et al. A case of Ebola virus infection. BMJ 1977; 2: 541-4
25. Baron RC, McCormick JB, Zubeir OA. Ebola hemorrhagic fever in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 1983; 6: 997-1003
26. Khan AS, Kweteminga TF, Heymann DL et al. The reemergence of Ebola hemorrhagic fever, Zaire, 1995. J Infect Dis 1998; In press
27. Zaki SR, Greer P, Shieh WU et al. A novel immunohisrocliemistry assay for detection of Ebola virus in skin: implications for diagnosis and surveillance of Ebola hemorrhagic fever. J Infect Dis 1998; 178: In press
28. Le Guenno B, Formentry P, Wyers M et al. Isolation and partial characterization of a new strain of Ebola virus. Lancet 1995; 345: 1271-4
29. World Health Organization. Ebola haemorrhagic fever - confirmed case in Côte d'Ivoire and suspect cases in Liberia. Wkly Epidemiol Rec 1995; 70: 359 30.
30. Amblard J, Obiang P, Prehaud C et al. Identification of the Ebola virus in Gabon in 1994. Lancet 1997; 349: 181-2
31. World Health Organization. Ebola haemorrhagic fever. Wkly Epidemiol Rec 1996; 71: 71
32. World Health Organization. Outbreak of haemorrhagic fever in Gabon officially declared over, Wkly Epidemiol Rec 1996; 71: 125-6
33. World Health Organization. Ebola haemorrhagic fever. Wkly Epidemiol Rec 1996; 71: 320
34. World Health Organization. Ebola haemorrhagic fever. Wkly Epidemiol Rec 1996; 71: 359
35. World Health Organization. Ebola haemorrhagic fever. Wkly Epidemiol Rec 1996; 71: 366
36. World Health Organization. Ebola haemorrhagic fever - a summary of the outbreak in Gabon. Wkly Epidemiol Rec 1997; 72: 7-8
37. World Health Organization. Ebola haemorrhagic fever. Wkly Epidemiol Rec 1997; 72: 23-4
38. World Health Organization. Ebola haemorrhagic fever. Wkly Epidemiol Rec 1997; 72: 71
39. Jahrling PB, Geisbert TW, Dalgard DW et al. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 1990; 335: 502-5
40. Centers for Disease Control and Prevention. Update: filovirus infection among persons with occupational exposure to nonhuman primates. Morbid Mortal Wkly Rep 1990; 39: 266-73
41. Peters CJ, Sanchez A, Feldmann H et al. Filoviruses as emerging pathogens. Semin Virol 1994; 5: 147-54
42. Centers for Disease Control and Prevention. Ebola-Reston virus infection among quarantined nonhuman primates - Texas, 1996. Morbid Mortal Wkly Rep 1996; 45: 314-6
43. Leirs H, Mills J, Krebs JW et al. Search for the Ebola-Reservoir in Kikwit: reflections on the vertebrate collection. J Infect Dis 1998; In press
44. Swanepoel R, Leman PA, Burt FJ et al. Experimental inoculation of plants and animals with Ebola virus. Etnerg Infect Dis 1996; 2: 321-5
45. Dowell SF, Mukunu R, Ksiazek TG et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Zaire; 1995. J Infect Dis 1998; 178: 00-00
46. Lloyd ES, Zaki SR, Rollin PE et al. Long-term disease surveillance in Bandundu Region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic Fever. J Infect Dis 1998; In press
47. Bazhutin NB, Belanov EF, Spiridonov VA et al. The effects of the methods for producing an experimental Marburg virus infection on the characteristics of the course of illness in green monkeys. Vopr Virusol 1992; 37: 153-6
48. Jahrling PB, Geisbert TW, Jaax NK et al. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 US epizootic. Arch Virol 1996; 11 (Suppl): 115-34
49. Johnson E, Jaax N, White J et al. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995; 76: 227-36
50. Jaax NK, Davis KJ, Geisbert TJ et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996; 120: 140-55
51. Cheprunov AA, Chuev YP, P'yankov OV et al. Effects of some physical and chemical factors of inactivation of Ebola virus. Vopr Virusul 1995; 2: 74-6
52. Kikiforov W, Turovskii II, Kalinin PP et al. A case of a laboratory infection with Marburg fever (in Russian). Zh Mikrobiol Epidemiol Immunobiol 1994; 3: 104-6
53. Stille W, Bohle E. Clinical course and prognosis of Marburg virus ('Green monkey') disease. In: Martini GA, Siegert R. (eds) Marburg Virus Disease. New York: Springer, 1971; 10-8
54. Todorovitch K, Mocitch M, Klasnja R, Clinical picture of two patients infected by rhe Marburg vervet virus. In: Martini GA, Siegert R. (eds) Marburg Virus Disease. New York: Springer, 1971; 19-23
55. Bwaka MA, Bonnet MJ, Calain P et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations. J Infect Dis 1998; In press
56. Schnittler HJ, Mahner F, Drenckhahn D et al. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease, J Clin Invest 1993; 91: 1301-9
57. Francois Villinger F, Rollin PE, Brar SS et al. Markedly elevated levels of interferon-γ/α, interleukin (IL)-2, IL-10, and tumor necrosis facror-α. J Infect Dis 1998; In press
58. Zaki SR, Peters CJ. Viral hemorrhagic fevers, Chapter 37. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE. (eds) The Pathology of Infections Diseases. Conn: Appleton and Lange, 1997; 347-64
59. Davis KJ, Anderson AO, Geisbert TW et al. Pathology of experimental Ebola virus infection in African green monkeys: involvement of fibroblastic reticular cells. Arch Pathol Lab Med 1997; 121: 805-19
60. Volchkov VE, Blinov VM, Netesov SV. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett 1992; 305: 181-4
61. Bukreyev A, Volchkov VE, Blinko VM et al. The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett 1993; 323: 183-7
62. Will C, Mühlberger E, Linder D et al. Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J Virol 1993; 67: 1203-10
63. Yang Z, Delgado R, Xu L et al. Distinct cellular interactions of the secreted and transmembrane Ebola virus glycoproteins: implication for viral pathogenesis. Science 1998; 279: 1034-7
64. Grob C. Tissue factor initiation of disseminated intravascular coagulation in filovirus infection. Med Hypotheses 1995; 45: 380-2
65. Ramanathan CS, Taylor EW. Computational genomic analysis of hemorrhagic fever viruses. Viral selenoproteins as a potential factor in pathogenesis. Biol Trace Elem Res 1997; 56: 93-106
66. Rowe A, Bertolli J, Khan AS et al. Clinical and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts Kikwit, Zaire. J Infect Dis 1998; In press
67. Martini GA, Schmidt HA. Spermatogenic transmission of the 'Marburg Virus' (translation). Klin Wschr 1968; 46: 398-400
68. McCormick JB, Bauer SP, Elliott LH et al. Biological differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis 1983; 347: 264-7
69. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISAs for the detection of antibodies to Ebola viruses. J Infect Dis 1998; In press
70. KsiazekTG, Rollin PE, Zaki SR et al. Virologrcal and serological diagnostics of Ebola hemorrhagic fever. J Infect Dis 1998; In press
71. Rollin PE, Williams RJ, Bressler D et al. Ebola virus, subtype Reston, among quarantined non-human primates recently imported from the Philippines to the United States. J Infect Dis 1998; In press
72. Kenyon RH, Niklasson J, Jahrling PB et al. Virologic investigation of a case of suspected hemorrhagic fever. Res Virol 1994; 145: 397-406
73. Busico KM, Marshall KL, Ksiazek TG et al. Prevalence of IgG antibodies to Ebola virus in healthy persons during an Ebola outbreak, Zaire, 1995. J Infect Dis 1998; In press
74. Rollin PE, Ksiazek TG, Jahrling PB et al. Detection of Ebola-like viruses by immunofluorescence. Lancet 1990; 336: 1591
75. Jahrling PB, Geisbert J, Swearengen JR et al. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol 1996; 11 (Suppl): 135-40
76. Jahrling PB, Geisbert TW, Geisbert JB et al. Evaluation of immune globulin and recombinant interferon α2b for treatment of experimental Ebola virus infections. J Infect Dis 1998; In press
77. Peters CJ, Sanchez A, Rollin PE, Ksiazek TG, Murphy FA. Filoviridae: Marburg and Ebola viruses. In: Fields BN, Knipe DM. (eds) Virology, 3rd edn. Philadelphia: Ceppiacott-Raven, 1996: 1161-76
78. Van der Groen G, Webb PA, Johnson KM, Lange J, Lindsey H, Eliott L. Growth of Lassa and Ebola viruses in different cell lines. In: Pattyn SR. (ed) Ebola Virus Haemorrhagic Fever. Amsterdam: Elsevier/North-Holland, 1978; 255-60
79. Kudoyarova-Zubavichene NM, Chepurnov AA, Sergeyev NN, Netesov SV. Preparation and use of hyperimmune serum for therapy of Filoviruses. J Infect Dis 1998; In press
80. Mupapa K, Masamba M, Kibadi K et al. Treatment of Ebola haemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 1998; In press
81. Sadek RF, Khan AS, Ksiazek TG et al. Ebola hemorrhagic fever, 1995: survival analysis. J Infect Dis 1998; In press
82. Maruyama T, Parren PWHI, Sanchez A et al. Recombinant human monoclonal antibodies to Ebola virus. J Infect Dis 1998; In press
83. Muggins J, Zhang ZX, Bray M. Antiviral drug therapy of Filovirus infections: S-adenosylhomocystein hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model. J Infect Dis 1998; In press
84. Clegg JC, Sanchez A. Vaccines against arenaviruses and filoviruses. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS. (eds) New Generation Vaccines, 2nd edn. New York: Marcel Dekker, 1997: 749-65
85. Xu L, Sanchez A, Yang Z et al. Genetic immunization for Ebola virus infection. Nat Med 1998; 4: 37-42
86. CDC/Center for Substance Abuse Treatment/National Institute on Drug Abuse. HIV AIDS prevention bulletin. Atlanta: US Department of Health and Human Services, Public Health Serives, CDC, April 19, 1993